Has Issued 5,000,000 Shares of Series A Preferred Stock

About Predictive Therapeutics

Predictive Therapeutics is a clinical stage oncology company, with a focus on immunotherapy. We seek to acquire undervalued late stage assets for clinical development. Our goal is to unlock the potential of these promising cancer therapies in order to bring effective and safe drugs to patients.

Contact Us for More Information

Would you like to learn more about working with Outcome Capital or discuss your specific needs?

Contact Us

  • Boston

    20 Custom House St, Suite 1200, Boston, MA 02110
    (617) 431-2278